EORTC SUMMIT ON CLINICAL CANCER RESEARCH 2027

ABOUT

Mission

The EORTC Summit aims to serve as a unique, high‑level forum bringing together all stakeholders involved in clinical cancer research. Its mission is to connect disciplines and perspectives to address the scientific, methodological, regulatory, and policy challenges of cancer research.

By convening the cancer research community in one place, the Summit seeks to foster collaboration and pragmatic solutions that advance patient‑centred, innovative, and sustainable clinical research.

Objectives

  • Provide a one‑stop, multi‑stakeholder platform where all key aspects of clinical cancer research are discussed in an integrated and practical manner;

  • Address topics such as advanced methodologies, pragmatic trials, registries, complex trial designs, data science, and emerging technologies;

  • Facilitate cross‑stakeholder dialogue and enhance collaboration between researchers, clinicians, industry, regulators, policymakers, funders, and patient representatives;

  • Strengthen the quality and relevance of evidence generation in clinical cancer research by focusing on real‑world applicability and methodological rigour.

JOIN US

Who should attend?

This clinical cancer research Summit brings together 
all stakeholders of the clinical cancer research landscape — from researchers, clinicians, and trialists to industry leaders, regulators, policymakers, funders, and patient representatives.

If you are involved in generating, evaluating, regulating, or applying clinical evidence in cancer, this Summit offers a unique opportunity to exchange perspectives, learn from others, and help break the boundaries of clinical cancer research.

Stakeholders - Illustration